Home / Conferences

Conferences

12TH EGA LEGAL AFFAIRS CONFERENCE

8‒9 March 2016
The Hotel Brussels, Belgium 

EBG BIOSIMILARS CONFERENCE 2016

The 14th Gathering of the World's Biosimilars Experts
28–29 april 2016
Grange Tower Bridge Hotel, London, UK 

6th Annual OTC Pharma Asia 2016

6th Annual OTC Pharma Asia 2016
1–4 March 2016
Singapore 

Pharmaceutical Congress China 2016

Pharmaceutical Congress China
 28–31 March 2016
 Grand Hyatt Shanghai, China 

Biopharma Development & Production 2016

Biopharma Development & Production 2016 incorporating:

- 5th Annual Cell Line Development & Engineering Asia
- 6th Annual Biomanufacturing
- 7th Annual Biosimilars Asia

16–19 May 2016

Grand Hyatt Shanghai, China

Extrapolation key issue at European biosimilars conference

The European Generic medicines Association (EGA) held its 13th EGA-European Biosimilars Group Conference in London on 23–24 April 2015.

French generics association promotes biosimilars

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Topics presented at the 16th IGPA conference on generics

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.

EGA pushes for increased focus on generics and biosimilars

EGA President Ms Gudbjorg Edda Eggertsdottir, speaking at the European Generic medicines Association’s (EGA’s) conferences in London, UK (11th EGA International Symposium on Biosimilar Medicines) and in Athens, Greece (19th EGA Annual Conference); stressed the importance of keeping generics and biosimilars manufacturers within Europe, thus ensuring that high quality manufacturing jobs and know-how remains in Europe. This would benefit society and patients and increase the competitiveness and innovative capacity of the pharmaceutical industry in Europe.

Report on 25th Annual EuroMeeting, 4-6 March 2013, Amsterdam, The Netherlands

Delegates at DIA’s 25th Anniversary of the EuroMeeting, held on 4–6 March 2013 in Amsterdam, The Netherlands, were offered the mouth watering prospect of more than 100 sessions across 17 themes, addressed by 300+ Speakers from EMA, European Commission, FDA and other national regulatory agencies. Most popular sessions included Implementation of the New Pharmacovigilance Legislation, the Regulatory Town Hall Meeting and the sell-out European Landscape on HTA - the EUnetHTA Joint Action. Eighteen pre-conference tutorials were led by an expert faculty and 120 students, young professional and patients all attended sessions created especially for them.